Recent health news highlights include Amgen addressing bone density concerns, AstraZeneca revising its financial outlook ...

AstraZeneca's China president has been detained by Chinese authorities amid investigation into illegal importation and ...

Neurogene shares tumbled 35% last night after it disclosed that a pediatric patient with Rett syndrome experienced a severe ...

Pfizer has made a new and improved bid to acquire AstraZeneca with an offer worth £69.3 billion pounds ($116.6 billion) or £55 a share – and says this is its best and final offer for the firm.

Pfizer has officially declared its £69 billion bid to acquire AstraZeneca dead - but hasn't ruled out another attempt in a few months' time. The US company has been in open pursuit of AstraZeneca ...

Other pharmaceutical players such as Roche, Amgen, Pfizer, AstraZeneca and Boehringer also have obesity drugs in the pipeline ...

Patrick Ruane, 55, was found guilty at the Old Bailey of two charges of encouraging terrorism in a series of Telegram posts ...

This article summarizes key developments in the health sector including a lawsuit blocking UnitedHealth's purchase of ...

Moderna stock rises as Q3 revenue beats estimates at $1.83 billion, driven by strong U.S. COVID-19 vaccine sales. EPS of $0.03 exceeds expectations.

Q3 2024 Earnings Conference Call November 7, 2024 4:30 PM ETCompany ParticipantsYvonne Briggs - Alliance Advisor, ...

Operator Good day, and welcome to the OPKO Health third quarter of 2024 financial results conference call. All participants ...

BioNTech will make $800mn in upfront payments to Biotheus, a drugmaker based in Guangdong province, with milestone payments of up to $150mn. Uğur Şahin, chief executive of BioNTech, said the company ...